Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gentian Kaloshi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|January 9, 2010
Up-front temozolomide in elderly patients with glioblastomaFlorence Laigle-Donadey, Dominique Figarella-Branger, Olivier Chinot, et al.
Journal of Neuro-Oncology|April 6, 2007
Association of telomerase gene hTERT polymorphism and malignant gliomasCatherine Carpentier, Julie Lejeune, Florent Gros, et al.
Fundamental & Clinical Pharmacology|December 10, 2016
Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical modelEdouard Ollier, Pauline Mazzocco, Damien Ricard, et al.
Journal of Neuro-Oncology|March 4, 2009
No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosisBlandine Boisselier, Yannick Marie, Soufiane El Hallani, et al.
Annals of Neurology|December 29, 2006
MGMT methylation: a marker of response to temozolomide in low-grade gliomasSibille Everhard, Gentian Kaloshi, Emmanuelle Crinière, et al.
Journal of Neuro-Oncology|July 9, 2011
Prophylactic intrathecal chemotherapy in primary CNS lymphomaMonica Sierra Del Rio, Damien Ricard, Caroline Houillier, et al.
Neuro-Oncology|February 13, 2010
Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomasCaroline Houillier, Karima Mokhtari, Catherine Carpentier, et al.
Journal of Neuro-Oncology|January 16, 2007
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalitiesEmmanuelle Crinière, Gentian Kaloshi, Florence Laigle-Donadey, et al.
Journal of Neuro-Oncology|April 26, 2011
Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expressionVirginie Desestret, Pietro Ciccarino, François Ducray, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|January 9, 2010
Up-front temozolomide in elderly patients with glioblastomaFlorence Laigle-Donadey, Dominique Figarella-Branger, Olivier Chinot, et al.
Journal of Neuro-Oncology|April 6, 2007
Association of telomerase gene hTERT polymorphism and malignant gliomasCatherine Carpentier, Julie Lejeune, Florent Gros, et al.
Fundamental & Clinical Pharmacology|December 10, 2016
Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical modelEdouard Ollier, Pauline Mazzocco, Damien Ricard, et al.
Journal of Neuro-Oncology|March 4, 2009
No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosisBlandine Boisselier, Yannick Marie, Soufiane El Hallani, et al.
Annals of Neurology|December 29, 2006
MGMT methylation: a marker of response to temozolomide in low-grade gliomasSibille Everhard, Gentian Kaloshi, Emmanuelle Crinière, et al.
Journal of Neuro-Oncology|July 9, 2011
Prophylactic intrathecal chemotherapy in primary CNS lymphomaMonica Sierra Del Rio, Damien Ricard, Caroline Houillier, et al.
Neuro-Oncology|February 13, 2010
Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomasCaroline Houillier, Karima Mokhtari, Catherine Carpentier, et al.
Journal of Neuro-Oncology|January 16, 2007
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalitiesEmmanuelle Crinière, Gentian Kaloshi, Florence Laigle-Donadey, et al.
Journal of Neuro-Oncology|April 26, 2011
Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expressionVirginie Desestret, Pietro Ciccarino, François Ducray, et al.
Pageof 3